4//SEC Filing
Geiger Uri 4
Accession 0001415889-25-018091
CIK 0001528287other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:30 PM ET
Size
18.1 KB
Accession
0001415889-25-018091
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Geiger Uri
Director
Transactions
- Award
Common Stock
2023-06-30$4.49/sh+2,337$10,493→ 2,337 total - Award
Common Stock
2024-03-29$13.20/sh+899$11,867→ 5,607 total - Award
Common Stock
2024-06-28$7.56/sh+1,570$11,869→ 7,177 total - Award
Common Stock
2025-06-21$10.41/sh+1,140$11,867→ 12,036 total - Award
Common Stock
2023-09-29$9.73/sh+1,220$11,871→ 3,557 total - Award
Common Stock
2023-12-29$10.31/sh+1,151$11,867→ 4,708 total - Award
Common Stock
2024-09-30$6.97/sh+1,703$11,870→ 8,880 total - Award
Common Stock
2024-12-21$11.53/sh+1,029$11,864→ 9,909 total - Award
Common Stock
2025-03-21$12.02/sh+987$11,864→ 10,896 total
Holdings
- 4,432,948(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
- [F2]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Geiger, a member of our board of directors, is a General Partner at Accelmed LLC.
Documents
Issuer
NeuroPace Inc
CIK 0001528287
Entity typeother
Related Parties
1- filerCIK 0001467361
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:30 PM ET
- Size
- 18.1 KB